Jove
Visualize
Contact Us

Related Experiment Videos

Contraceptive options for the 1990s

E C McGuffey

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
    |March 1, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Combination oral contraceptives (COCs) require strict adherence for effectiveness. Progesterones inhibit ovulation and thicken cervical mucus. Mifepristone/misoprostol and IUDs offer alternative contraceptive options.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Computerized DUR alerts: boon or bane to pharmaceutical care?

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·1998
    Same author

    Alzheimer's disease: an overview for the pharmacist.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·1997
    Same author

    Treating hot flashes.

    American pharmacy·1995
    Same author

    Treatment of the common cold in children.

    American pharmacy·1994
    Same author

    H. pylori and ulcers.

    American pharmacy·1994
    Same author

    Combining aspirin with other NSAIDs.

    American pharmacy·1994
    Same journal

    The Sky is His Wife (2001)/Jim Alford (b. 1943).

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
    Same journal

    Zada Mary cooper (1875-1961).

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
    Same journal

    Aiming for, believing in, and achieving a target a1c of less than 7.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
    Same journal

    Evaluation of OTC Product Information in Three Drug Information Databases for PDAs.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
    Same journal

    New biotechnology approvals for 2002.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
    Same journal

    Preventing meningococcal outbreaks: an opportunity for pharmacists.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Reproductive Health
    • Contraception
    • Pharmacology

    Background:

    • Combination oral contraceptives (COCs) are widely used but demand strict adherence.
    • Progesterones in contraceptives function by inhibiting ovulation, altering cervical mucus, and affecting the endometrium.
    • Various contraceptive methods, including mifepristone/misoprostol and IUDs, present different risk-benefit profiles and adherence requirements.

    Purpose of the Study:

    • To review the efficacy, safety, and adherence considerations of different contraceptive methods.
    • To inform healthcare providers and patients about the advantages and disadvantages of various contraceptive options.
    • To highlight the FDA's stance on the mifepristone/misoprostol regimen.

    Main Methods:

    • Literature review of contraceptive efficacy and safety data.

    Related Experiment Videos

  • Analysis of FDA advisory committee conclusions.
  • Comparative assessment of hormonal contraceptives, intrauterine devices (IUDs), and barrier methods.

    • Main Results:

    • COCs offer high reliability but necessitate strict dosing adherence.
    • Progestin's mechanisms include ovulation inhibition and cervical mucus thickening.
    • Mifepristone/misoprostol regimen benefits are deemed to outweigh risks by an FDA committee.
    • IUDs provide a convenient, long-acting option for suitable candidates.
    • Barrier methods are accessible and inexpensive but less effective.

    Conclusions:

    • Contraceptive choice depends on individual needs, adherence capabilities, and risk tolerance.
    • Understanding the mechanisms and adherence requirements of each method is crucial for effective family planning.
    • The landscape of contraception includes reliable hormonal options, effective long-acting methods, and accessible barrier choices.